Blue Crest Capital Management LTD Alector, Inc. Transaction History

Blue Crest Capital Management LTD

  • $1.62 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 14, 2020
SELL
$14.17 - $20.3 $270,576 - $387,628
-19,095 Closed
0 $0
Q2 2019

Aug 14, 2019
BUY
$16.26 - $26.42 $42,194 - $68,559
2,595 Added 15.73%
19,095 $363,000
Q1 2019

May 15, 2019
BUY
$15.97 - $22.5 $263,505 - $371,250
16,500 New
16,500 $309,000

Others Institutions Holding ALEC

# of Institutions
164
Shares Held
57.5M
Call Options Held
146K
Put Options Held
90.8K
View Full List

About Alector, Inc.

ALEC Quotes by TradingView
  • Ticker ALEC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 82,563,904
  • Market Cap $144M
  • Description
  • Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...
More about ALEC
Track This Portfolio

Track Blue Crest Capital Management LTD Portfolio

Follow Blue Crest Capital Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blue Crest Capital Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Blue Crest Capital Management LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email